PAPER Zhou S, Liu D, Chen J, Xiang C, Xiang J, Yang M
SEARCH RESULTS
300519 RESULTS
PAPER Rapeaux A, Syed O, Cuttaz E, Chapman CA, Green RA, Constandinou TG
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.
J Vis Exp. 2022 Jul 12;(185) PubMed.PAPER Beaglehole B, Newton-Howes G, Porter R, Frampton C
A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy.
BJPsych Open. 2022 Aug 1;8(5):e145. PubMed.PAPER Riederer I, Mühlau M, Wiestler B, Bender B, Hempel JM, Kowarik M, Huber T, Zimmer C, Andrisan T, Patzig M, Zimmermann H, Havla J, Berlis A, Behrens L, Beer M, Dietrich J, Sollmann N, Kirschke JS
A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy.
Rofo. 2022 Jul 29; PubMed.PAPER Meyer T, Spittel S, Grehl T, Weyen U, Steinbach R, Kettemann D, Petri S, Weydt P, Günther R, Baum P, Schlapakow E, Koch JC, Boentert M, Wolf J, Grosskreutz J, Rödiger A, Ilse B, Metelmann M, Norden J, Koc RY, Körtvélyessy P, Riitano A, Walter B, Hildebrandt B, Schaudinn F, Münch C, Maier A
Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.
Amyotroph Lateral Scler Frontotemporal Degener. 2022 Aug 1;:1-10. PubMed.PAPER Khorrami M, Saneipour M, Moridnia A, Shaygannejad V, Sadeghi E, Kassani A, Sarmadi A, Mirmosayyeb O
Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy.
Int J Neurosci. 2022 Oct 20;:1-6. PubMed.PAPER Testino G
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.
Minerva Med. 2022 Aug;113(4):730. PubMed.PAPER Liampas I, Hatzimanolis A, Siokas V, Yannakoulia M, Kosmidis MH, Sakka P, Hadjigeorgiou GM, Scarmeas N, Dardiotis E
Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type III hyperlipoproteinemia.
J Alzheimers Dis. 2022;89(2):709-719. PubMed.PAPER Cascini S, Agabiti N, Marino C, Acampora A, Balducci M, Calandrini E, Davoli M, Bargagli AM
Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant.
J Alzheimers Dis. 2022;89(2):681-693. PubMed.PAPER Xu Q, Zou K, Deng Z, Zhou J, Dang X, Zhu S, Liu L, Fang C
Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant.
J Alzheimers Dis. 2022;89(2):669-679. PubMed.PAPER Janssen N, Handels RL, Wimo A, Antikainen R, Laatikainen T, Soininen H, Strandberg T, Tuomilehto J, Kivipelto M, Evers SM, Verhey FR, Ngandu T
A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
J Alzheimers Dis. 2022;89(2):623-632. PubMed.PAPER Eliseeva DD, Zakharova MN
A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(7. Vyp. 2):5-13. PubMed.PAPER Foxe D, Hu A, Cheung SC, Ahmed RM, Cordato NJ, Devenney E, Hwang YT, Halliday GM, Mueller N, Leyton CE, Hodges JR, Burrell JR, Irish M, Piguet O
The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Brain Commun. 2022;4(4):fcac161. Epub 2022 Jul 7 PubMed.PAPER Gao L, Cao M, Du GH, Qin XM
The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
Front Aging Neurosci. 2022;14:911924. Epub 2022 Jul 15 PubMed.PAPER Aldosari DI, Malik A, Alhomida AS, Ola MS
A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy.
Front Neurosci. 2022;16:938029. Epub 2022 Jul 13 PubMed.Current Filters
No filters selected